Head-to-head · WeighScore
JM Integrated Health vs ReadyRx
The verdict
ReadyRx takes it — 67.8/100 to 55.9/100.
ReadyRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. ReadyRx (readyrx.com) is a LegitScript-certified US telehealth provider offering compounded semaglutide from $179/mo and compounded tirzepatide from $255/mo, plus NAD+, sermorelin, glutathione, MIC+B12, and…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | JM Integrated Health | ReadyRx |
|---|---|---|
| WeighScore | 55.9/100 | 67.8/100 |
| Grade | C | C |
| Scorecard rank | #427 | #156 |
| Semaglutide | Not disclosed | $179/mo (starting dose, compounded) |
| Tirzepatide | Not disclosed | $255/mo (starting dose, compounded) |
| Coverage | 6 states | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #427 · C
Strengths
- Transparent cash-pay pricing — $149 enrollment plus $99/month, no hidden fees
- Medication cost is billed separately by the pharmacy, so the program fee isn't inflated by drug markup
- Six states clearly listed (TX, VT, NM, AZ, WA, NV)
- Named provider — John Meyer, FNP-C, board-certified, 10+ years' experience
- Publishes the FDA compounded-medication disclaimer
Where it loses points
- 503A pharmacy partner not named publicly
- Single-provider practice — enrollment is capacity-limited
- Only six states served, vs nationwide competitors
- Total monthly cost is the program fee plus a separate pharmacy bill, not one all-in price
- No LegitScript certification displayed
Graded #156 · C
Strengths
- LegitScript Certified — verifiable via the badge link in the footer
- Batch lab testing covers the right QA metrics for injectables: potency, sterility, pH, and endotoxicity
- Pricing shown publicly: $179/mo semaglutide, $255/mo tirzepatide
Where it loses points
- Pharmacy partners not named — only described as 'FDA-registered compounding pharmacies'
- Clinicians described as licensed and board-certified, but no names or credentials published
- 5,000+ member figure comes from a directory listing, not an independent audit
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.